In recent years, interest in dietary fiber has grown significantly, especially in relation to its impact on gut health and ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

The luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

ALBAWABA - The popular weight loss drug, Ozempic is causing panic among its users after experts revealed an alarming side ...

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...